178.
Endothelial dysfunction is associated with carotid plaque: a cross-sectional
study from the population based Northern Manhattan Study / T. Rundek [et al.] //
BMC. Cardiovasc. Disord. – 2006. – № 6. – P. 35.
179.
Endothelial dysfunction: a comprehensive appraisal / R. J. Esper [et al.] //
Cardiovasc. Diabetol. – 2006. – Vol. 5. – P. 4.
180.
Endothelium-dependent dilation in the systemic arteries of asymptomatic
subjects relates to coronary risk factors and their interaction / D. S. Celermajer [et
al.] // J. Am. Coll. Cardiol. – 1994. – Vol. 24, № 6. – P. 1468-1474.
181.
Endothelium-dependent vasodilation is related to the fatty acid composition of
serum lipids in healthy subjects / M. Sarabi [et al.] // Atherosclerosis. – 2001. –
Vol. 156, № 2. – Р. 349-355.
182.
Ernsberg P. Molecular pathology in obese spontaneous hypertensive Koletsky
rat: a model of syndrome X / P. Ernsberg, R. J. Koletsky, J. E. Friedman // Ann.
NY Acad. Sci. – 1999. – Vol. 892. – P. 272-288.
183.
European guidelines on cardiovascular disease prevention in clinical practice.
Third Joint Task Force of European and other Societies on Cardiovascular Disease
Prevention in Clinical Practice / G.
Eur. Heart J. – 2003. – Vol. 24,
№ 17. – Р. 1601-1610.
184.
European Society of Hypertension-European Society of Cardiology guidelines
for the management of arterial hypertension-2003 //
185.
Extra-adipocyte leptin release in human obesity and its relation to
sympathoadrenal function / N. Eikelis [et al.] // Am. J. Physiol. Endocrinol.
Metab. – 2004. – Vol. 286, № 5 . – P. 744-752.
186.
Finer N. Sibutramine trial of obesity reduction and maintenance - efficacy
during the 6-month run-in-phase / N. Finer // Int. J. Obesity Suppl. – 1998. – Vol.
3, № 22. – P. 272.
